AI impacting all of healthcare – but not at same pace, says Mérieux’s Jean-François Billet; Private capital ‘keen’ to be part of UK defense plans
'Drug discovery is accelerated by AI because you can screen a lot of compounds much faster,' Jean-François Billet, head of buyout at Mérieux, told PE Hub.
23 June 2026•3 mins read
